Nature 398, 341— 344 (1999).
It has come to our attention that the conclusions drawn in this paper need to be revised. We have found that the effects attributed to CD30 were the result of background gene(s) of 129 origin. Subsequent backcrossing of the CD30-deficient OT-I line by G. Davey in our laboratory segregated the capacity of low numbers of OT-I cells to cause disease from their capacity to express CD30. Our conclusion that signalling through CD30 protects against autoimmune diabetes must be reconsidered as an effect of a background gene(s) that we are currently mapping.
Additional information
The online version of the original article can be found at 10.1038/18692
Rights and permissions
About this article
Cite this article
Kurts, C., Carbone, F., Krummel , M. et al. Correction: Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 407, 413 (2000). https://doi.org/10.1038/35030185
Issue Date:
DOI: https://doi.org/10.1038/35030185
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
